DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
+18.6%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$6.69B
AUM Growth
+$682M
(+11%)
Cap. Flow
-$874M
Cap. Flow
% of AUM
-13.05%
Top 10 Holdings %
Top 10 Hldgs %
54.02%
Holding
681
New
246
Increased
85
Reduced
72
Closed
235
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$72.1M |
| 2 |
Indivior
INDV
|
$49.7M |
| 3 |
BCAX
Bicara Therapeutics Inc. Common Stock
BCAX
|
$45.7M |
| 4 |
Merus
MRUS
|
$32.9M |
| 5 |
Viatris
VTRS
|
$30.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$102M |
| 2 |
Surgery Partners
SGRY
|
$94.4M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
$57.6M |
| 4 |
BioNTech
BNTX
|
$49.8M |
| 5 |
Integra LifeSciences
IART
|
$42.8M |
Sector Composition
| 1 | Healthcare | 87.45% |
| 2 | Industrials | 0.72% |
| 3 | Technology | 0.55% |
| 4 | Financials | 0.42% |
| 5 | Consumer Discretionary | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
551
Ambac
AMBC
$426M
| – | – |
-89,619
| Closed | -$1.15M |
|
552
Ametek
AME
$43.4B
| – | – |
-3,011
| Closed | -$502K |
|
553
Amphastar Pharmaceuticals
AMPH
$1.36B
| – | – |
-6,623
| Closed | -$265K |
|
554
AutoNation
AN
$8.51B
| – | – |
-3,204
| Closed | -$511K |
|
555
AngioDynamics
ANGO
$436M
| – | – |
-109,536
| Closed | -$663K |
|
556
ANI Pharmaceuticals
ANIP
$2.08B
| – | – |
-5,138
| Closed | -$327K |
|
557
Apogee Therapeutics
APGE
$2.21B
| – | – |
-329,000
| Closed | -$12.9M |
|
558
Appian
APPN
$2.22B
| – | – |
-14,027
| Closed | -$433K |
|
559
Aptiv
APTV
$17.5B
| – | – |
-5,980
| Closed | -$421K |
|
560
Arcturus Therapeutics
ARCT
$455M
| – | – |
-39,328
| Closed | -$958K |
|
561
Alexandria Real Estate Equities
ARE
$14.2B
| – | – |
-3,399
| Closed | -$398K |
|
562
Ares Management
ARES
$39.5B
| – | – |
-4,175
| Closed | -$556K |
|
563
Aris Water Solutions
ARIS
$786M
| – | – |
-55,490
| Closed | -$870K |
|
564
Arlo Technologies
ARLO
$1.9B
| – | – |
-14,145
| Closed | -$184K |
|
565
Archrock
AROC
$4.47B
| – | – |
-60,016
| Closed | -$1.21M |
|
566
AtriCure
ATRC
$1.77B
| – | – |
-17,068
| Closed | -$389K |
|
567
Avanos Medical
AVNS
$587M
| – | – |
-27,654
| Closed | -$551K |
|
568
Avery Dennison
AVY
$13B
| – | – |
-2,504
| Closed | -$548K |
|
569
Bank of America
BAC
$375B
| – | – |
-6,029
| Closed | -$240K |
|
570
Bain Capital Specialty
BCSF
$1.02B
| – | – |
-79,569
| Closed | -$1.3M |
|
571
Brighthouse Financial
BHF
$2.53B
| – | – |
-6,219
| Closed | -$270K |
|
572
Blackbaud
BLKB
$3.22B
| – | – |
-4,884
| Closed | -$372K |
|
573
BOK Financial
BOKF
$7.19B
| – | – |
-12,026
| Closed | -$1.1M |
|
574
BRC Inc
BRCC
$172M
| – | – |
-54,611
| Closed | -$335K |
|
575
Braze
BRZE
$2.92B
| – | – |
-7,995
| Closed | -$311K |
|